These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17940502)

  • 61. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The expression of MCM-2 in invasive breast carcinoma: a stereologic approach.
    Cobanoglu U; Mungan S; Gundogdu C; Ersoz S; Ozoran Y; Aydin F
    Bratisl Lek Listy; 2010; 111(1):45-9. PubMed ID: 20429312
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors.
    Newcomb EW; Sosnow M; Demopoulos RI; Zeleniuch-Jacquotte A; Sorich J; Speyer JL
    Am J Pathol; 1999 Jan; 154(1):119-25. PubMed ID: 9916926
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer.
    Dong Y; Walsh MD; McGuckin MA; Cummings MC; Gabrielli BG; Wright GR; Hurst T; Khoo SK; Parsons PG
    Int J Cancer; 1997 Aug; 74(4):407-15. PubMed ID: 9291430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
    Hjortkjær M; Waldstrøm M; Jakobsen A; Kanstrup H; Søgaard-Andersen E; Dahl Steffensen K
    Int J Gynecol Pathol; 2017 Mar; 36(2):180-189. PubMed ID: 27362900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
    Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
    Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
    Shuang T; Wang M; Zhou Y; Shi C
    Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM; El-Etreby NM
    Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.
    Shimizu M; Nikaido T; Toki T; Shiozawa T; Fujii S
    Cancer; 1999 Feb; 85(3):669-77. PubMed ID: 10091740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir IA; Sorbe B; Lindborg K; Seidal T
    Int J Gynecol Cancer; 2011 Feb; 21(2):236-44. PubMed ID: 21270607
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
    Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
    Kaern J; Aghmesheh M; Nesland JM; Danielsen HE; Sandstad B; Friedlander M; Tropé C
    Int J Gynecol Cancer; 2005; 15(6):1014-22. PubMed ID: 16343177
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers.
    de la Torre J; Gil-Moreno A; García A; Rojo F; Xercavins J; Salido E; Freire R
    Int J Gynecol Pathol; 2008 Jan; 27(1):24-32. PubMed ID: 18156970
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
    Paek J; Lee M; Nam EJ; Kim SW; Kim YT
    Arch Gynecol Obstet; 2016 Mar; 293(3):645-50. PubMed ID: 26305032
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
    Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
    J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins.
    Tachibana M; Watanabe J; Matsushima Y; Nishida K; Kobayashi Y; Fujimura M; Shiromizu K
    Int J Gynecol Cancer; 2003; 13(5):598-606. PubMed ID: 14675342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.